News

An innovative imaging technique enabled dramatically higher resolution structures than previous efforts.

Alison Cahill of The University of Texas at Austin is a part of the Dell Medical School and Texas Biologics steering committee.

A new antibody design blocks cytomegalovirus from hiding from the immune system and could lead to safer, more effective treatments for vulnerable patients.

The breakthrough could be used in a new vaccine or antibody therapy to fight mpox, the disease caused by the monkeypox virus.

The award recognizes Jason McLellan’s work to investigate how viruses infect our cells and to develop new treatments for infectious disease.

Key antibodies use a clever trick to slip deep into a bacteria’s outer membrane, where they can do real damage.

With support from the Cancer Prevention and Research Institute of Texas, molecular bioscientist Dima Kozakov joins UT.

In early 2020, the world’s spotlight shined on The University of Texas at Austin.

The connection between research and real life is never so direct—or crucial—as it is in the field of health care.

Graduate students at The University of Texas at Austin have a new opportunity to revolutionize how medicines are developed and delivered.